The board of directors of Sinopharm Group Co. Ltd. announced that on 10 June 2022, Mr. Deng Jindong, a non-executive director of the Company, resigned as a member of the audit committee and remuneration committee of the Board due to other work arrangements, with immediate effect. Mr. Deng Jindong will continue to serve as a non-executive director of the Company and a member of the strategy and investment committee of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.6 HKD | 0.00% | +8.95% | +5.38% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.38% | 8.32B | |
+15.65% | 69.91B | |
+2.72% | 25.14B | |
+6.10% | 8.07B | |
-21.85% | 7.97B | |
+0.73% | 4.56B | |
+17.40% | 4.31B | |
-0.14% | 3.99B | |
-2.34% | 3.87B | |
+21.03% | 3.63B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Committee and Remuneration Committee of Board